在胰腺管腺癌中使用网络理论方法识别关键调节器
Kankana Bhattacharjee1, Aryya Ghosh1
1Department of Chemistry, Ashoka University, Sonipat, Haryana, India.
PloS one
|January 27, 2025
概括
这项研究通过分析基因表达来确定胰腺管腺癌 (PDAC) 中的关键基因调节体. 这些调节剂为这种具有挑战性的癌症提供了新的诊断生物标志物和向治疗的潜力.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 系统生物学 系统生物学
背景情况:
- 胰腺管腺癌 (PDAC) 由于检测迟到和治疗耐药性,表现不佳.
- 涉及遗传和环境因素的PDAC复杂的分子机制仍然不太了解.
- 揭开PDAC的遗传特征对于我们更好地理解和治疗至关重要.
研究的目的:
- 与健康对照组相比,在PDAC中识别差异表达基因 (DEGs).
- 使用DEGs构建和分析PDAC的蛋白相互作用网络.
- 确定关键的调节基因及其潜在的治疗和生物标志物意义.
主要方法:
- 对PDAC和健康对照的基因表达概况.
- 对差异表达基因 (DEGs) 的鉴定.
- 构建和拓分析PDAC蛋白相互作用网络,包括使用LEV方法进行社区检测.
主要成果:
- PDAC网络表现出一个没有规模的,弱层次的组织.
- 确定了33个关键调节器,在神经活性联体受体相互作用和细胞粘附等途径中得到丰富.
- 这些调节器参与细胞增殖和信号传递,并确定了潜在的治疗点和批准的药物.
结论:
- 已识别的关键调节剂具有作为胰腺管道腺癌的生物标志物和治疗点的巨大潜力.
- 对这些关键调节物的实验验证是必不可少的,以确认它们在PDAC治疗中的有效性.
- 这种基于网络的方法为PDAC的分子景观和治疗途径提供了洞察力.
相关概念视频
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K